Eton Pharmaceuticals, Inc. (ETON) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 08/07/25
Eton Pharmaceuticals, Inc. (ETON) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 07/31/25
Eton Pharmaceuticals to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025GlobeNewsWire • 07/28/25
Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)GlobeNewsWire • 07/08/25
Eton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® IndexesGlobeNewsWire • 06/27/25
Eton Pharmaceuticals: Rapid Revenue Growth And Pipeline Catalysts Point To More UpsideSeeking Alpha • 06/06/25
Eton Pharmaceuticals (ETON) Is a Great Choice for 'Trend' Investors, Here's WhyZacks Investment Research • 06/02/25
FDA Approves Eton Pharma's Oral Drug For Adrenal Insufficiency In Pediatric Patients, Analyst Sees Boost In 2025 RevenueBenzinga • 05/29/25
Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral SolutionGlobeNewsWire • 05/28/25
Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025GlobeNewsWire • 05/01/25
Eton Pharmaceuticals, Inc. (ETON) Earnings Expected to Grow: What to Know Ahead of Q1 ReleaseZacks Investment Research • 05/01/25
Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)GlobeNewsWire • 04/28/25
CROSSJECT updates on its collaboration with ETON PHARMACEUTICALS, Inc. and the ZENEO® adrenal insufficiency programGlobeNewsWire • 03/25/25
Eton Pharmaceuticals, Inc. (ETON) Virtual Investor Day and Q4 2024 Earnings Call TranscriptSeeking Alpha • 03/18/25
Eton Pharmaceuticals, Inc. (ETON) Reports Q4 Loss, Tops Revenue EstimatesZacks Investment Research • 03/18/25